AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 28 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $20,111,000 | -22.9% | 18,400,000 | 0.0% | 0.31% | -7.4% |
| Q4 2016 | $26,068,000 | +25.3% | 18,400,000 | 0.0% | 0.34% | +8.4% |
| Q3 2016 | $20,808,000 | +2.1% | 18,400,000 | +0.1% | 0.31% | +0.6% |
| Q2 2016 | $20,380,000 | -13.5% | 18,385,000 | -15.3% | 0.31% | -53.9% |
| Q1 2016 | $23,567,000 | -14.2% | 21,709,000 | 0.0% | 0.67% | +13.2% |
| Q4 2015 | $27,469,000 | -21.3% | 21,709,000 | 0.0% | 0.59% | -28.2% |
| Q3 2015 | $34,904,000 | -36.0% | 21,709,000 | +2.8% | 0.82% | -33.4% |
| Q2 2015 | $54,577,000 | +24.3% | 21,109,000 | 0.0% | 1.24% | +41.5% |
| Q1 2015 | $43,900,000 | +24.4% | 21,109,000 | 0.0% | 0.88% | +27.4% |
| Q4 2014 | $35,289,000 | +24.9% | 21,109,000 | 0.0% | 0.69% | +16.4% |
| Q3 2014 | $28,246,000 | +26.1% | 21,109,000 | 0.0% | 0.59% | +20.2% |
| Q2 2014 | $22,399,000 | +4.0% | 21,109,000 | 0.0% | 0.49% | +6.5% |
| Q1 2014 | $21,536,000 | – | 21,109,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 17,250,000 | $19,597,000 | 18.38% |
| STEELHEAD PARTNERS LLC | 17,000,000 | $19,264,000 | 1.88% |
| Bruce & Co., Inc. | 5,500,000 | $6,600,000 | 1.78% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 26,750,000 | $30,177,000 | 1.01% |
| Castle Creek Arbitrage, LLC | 3,721,000 | $4,215,000 | 0.43% |
| LINDEN ADVISORS LP | 7,000,000 | $7,909,000 | 0.36% |
| Sonora Investment Management, LLC | 1,510,000 | $1,702,676,000 | 0.36% |
| BASSO CAPITAL MANAGEMENT, L.P. | 2,110,000 | $2,382,000 | 0.35% |
| WOLVERINE ASSET MANAGEMENT LLC | 18,400,000 | $20,808,000 | 0.31% |
| SSI INVESTMENT MANAGEMENT LLC | 1,975,000 | $2,221,000 | 0.20% |